Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure.

ABSTRACT:

Background

An increasing number of reports have described the COVID-19-associated pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on a recent consensus statement supported by international medical mycology societies, it has been proposed to define CAPA as possible, probable, or proven on the basis of sample validity and thus diagnostic certainty. Considering current challenges associated with proven diagnoses, there is pressing need to study the epidemiology of proven CAPA.

Methods

We report the incidence of histologically diagnosed CAPA in a series of 45 consecutive COVID-19 laboratory-confirmed autopsies, performed at Padova University Hospital during the first and second wave of the pandemic. Clinical data, laboratory data and rad

SUBMITTER: Fortarezza F 

PROVIDER: S-EPMC8446949 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature